Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Over the next five years, new plants will be built in the United States and create 3,000 jobs for qualified workers.
Eli Lilly plans to spend at least $ 27 billion to build four new production plants in the United States, drug receiving, Trump management said they are in danger of importing duties.
Over the next five years, new plants will be built and will create more than 3,000 jobs for qualified workers such as engineers and scientists at Washington press conference on Washington.
Lilly said that at the end of this year, the sites will announce the places.
A week later a week later, US President Donald Trump met with Lilly CEO David Ricks, including Lilly CEO David Ricks, which discussed materials such as tariffs on drug imports.
US Trade Secretary Howard Lutnick, Lilly’s Lilly was “fully the president,” he said.
Ricks said the government hopes that potential tariffs will be released from medical supplies and continue subsequent tax reforms.
CEO, in a statement on Wednesday, said that the tax cutting legislation applied in the first term of Trump is the foundation for domestic production investments.
Increase internal production
Trump, which is encouraged in a promise to increase domestic production, has pressured medical production since the office leading to the United States. Last week, he said that pharmacy and other imports could apply a duty for a 25 percent.
Other sectors also make production ads. This week ago, Apple said it would spend $ 500 billion In the next four years in the United States, but analysts said that part of this includes the existing obligations.
According to the United States and its main trade partners, the US trade office, the US trade representative agreed to eliminate the reciprocal tariff for pharmaceutical products and drugs used in drug production in the last 30 years.
Despite the beginning of this month in the beginning of this month, despite the explanation of a meeting of a white house, he looked at such a freedom, Trump must still handle them.
Answering a question about the federal operation of the US food and drug management, CEO Lilly’s fees went to the agency’s financing employees and these funds will be “focused on something else”.
Lilly, which has become the most valuable health care company worth $ 855 billion, has already earned $ 23 billion to increase US production trace since 2020, he said. Wednesday announcement is more than $ 50 billion.
Lilly’s new plants will be used to produce three pharmaceutical raw materials, will prepare the fourth injection drugs, the pharmacy said.
